Home LiteratureArticle Details
PMID: 15793130 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations.

Antimicrobial agents and chemotherapy ·Vol. 49 ·No. 4 ·2005-04-00 ·Pages 1483-94

Wiuff C, Zappala RM, Regoes RR, Garner KN, Baquero F, Levin BR

Abstract

When growing bacteria are exposed to bactericidal concentrations of antibiotics, the sensitivity of the bacteria to the antibiotic commonly decreases with time, and substantial fractions of the bacteria survive. Using Escherichia coli CAB1 and antibiotics of five different classes (ampicillin, ciprofloxacin, rifampin, streptomycin, and tetracycline), we examine the details of this phenomenon and, with the aid of mathematical models, develop and explore the properties and predictions of three hypotheses that can account for this phenomenon: (i) antibiotic decay, (ii) inherited resistance, and (iii) phenotypic tolerance. Our experiments cause us to reject the first two hypotheses and provide evidence that this phenomenon can be accounted for by the antibiotic-mediated enrichment of subpopulations physiologically tolerant to but genetically susceptible to these antibiotics, phenotypic tolerance. We demonstrate that tolerant subpopulations generated by exposure to one concentration of an antibiotic are also tolerant to higher concentrations of the same antibiotic and can be tolerant to antibiotics of the other four types. Using a mathematical model, we explore the effects of phenotypic tolerance to the microbiological outcome of antibiotic treatment and demonstrate, a priori, that it can have a profound effect on the rate of clearance of the bacteria and under some conditions can prevent clearance that would be achieved in the absence of tolerance.

MeSH Terms
Anti-Bacterial Agents/administration & dosage,pharmacology Colony Count, Microbial Computer Simulation Culture Media Drug Resistance, Bacterial Drug Tolerance Escherichia coli/drug effects,growth & development Humans Microbial Sensitivity Tests/methods Models, Biological Phenotype
Chemicals
Anti-Bacterial Agents Culture Media
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Wiuff C
Department of Biology, Emory University, 1510 Clifton Rd., Atlanta, Georgia 30322, USA. cwiuff@emory.edu
Zappala R M
Regoes R R
Garner K N
Baquero F
Levin B R
References (39)
39 references, click to expand
  1. SOS response induction by beta-lactams and bacterial defense against antibiotic lethality.
    Science. 2004 Sep 10;305(5690):1629-31 PMID: 15308764
  2. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli.
    J Bacteriol. 2004 Dec;186(24):8172-80 PMID: 15576765
  3. Pharmacodynamic functions: a multiparameter approach to the design of antibiotic treatment regimens.
    Antimicrob Agents Chemother. 2004 Oct;48(10):3670-6 PMID: 15388418
  4. Phenotypic tolerance: the search for beta-lactam antibiotics that kill nongrowing bacteria.
    Rev Infect Dis. 1986 Jul-Aug;8 Suppl 3:S279-91 PMID: 3529321
  5. The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth.
    J Gen Microbiol. 1986 May;132(5):1297-304 PMID: 3534137
  6. Antibiotic tolerance among clinical isolates of bacteria.
    Antimicrob Agents Chemother. 1986 Oct;30(4):521-7 PMID: 3539006
  7. Morphological and biochemical changes in Escherichia coli after exposure to ciprofloxacin.
    J Antimicrob Chemother. 1986 Nov;18 Suppl D:31-41 PMID: 3542947
  8. General method for site-directed mutagenesis in Escherichia coli O18ac:K1:H7: deletion of the inducible superoxide dismutase gene, sodA, does not diminish bacteremia in neonatal rats.
    Infect Immun. 1989 Jul;57(7):2141-8 PMID: 2543632
  9. The post-antibiotic effect defined by bacterial morphology.
    J Antimicrob Chemother. 1989 Apr;23(4):485-91 PMID: 2663811
  10. Comparative killing rates of fluoroquinolones and cell wall-active agents.
    Antimicrob Agents Chemother. 2000 May;44(5):1377-80 PMID: 10770784
  11. A combined in vivo pharmacokinetic-in vitro pharmacodynamic approach to simulate target site pharmacodynamics of antibiotics in humans.
    J Antimicrob Chemother. 2000 Nov;46(5):733-9 PMID: 11062192
  12. Aminoglycoside adaptive resistance: importance for effective dosage regimens.
    Drugs. 2001;61(6):713-21 PMID: 11398904
  13. Stochastic gene expression in a single cell.
    Science. 2002 Aug 16;297(5584):1183-6 PMID: 12183631
  14. Dynamics of success and failure in phage and antibiotic therapy in experimental infections.
    BMC Microbiol. 2002 Nov 26;2:35 PMID: 12453306
  15. Persister cells and tolerance to antimicrobials.
    FEMS Microbiol Lett. 2004 Jan 15;230(1):13-8 PMID: 14734160
  16. Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC.
    Antimicrob Agents Chemother. 2004 Feb;48(2):369-77 PMID: 14742182
  17. Killing by ampicillin and ofloxacin induces overlapping changes in Escherichia coli transcription profile.
    Antimicrob Agents Chemother. 2004 Mar;48(3):890-6 PMID: 14982780
  18. From molecular noise to behavioural variability in a single bacterium.
    Nature. 2004 Apr 1;428(6982):574-8 PMID: 15058306
  19. Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation.
    J Infect Dis. 1990 Aug;162(2):414-20 PMID: 2115555
  20. The vir locus affects the response of Bordetella pertussis to antibiotics: phenotypic tolerance and control of autolysis.
    J Infect Dis. 1990 Aug;162(2):560-3 PMID: 2373881
  21. First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use.
    Antimicrob Agents Chemother. 1991 Jan;35(1):117-23 PMID: 2014966
  22. Biphasic kinetics of bacterial killing by quinolones.
    J Antimicrob Chemother. 1991 Mar;27(3):319-27 PMID: 2037537
  23. Mechanism of phenotypic tolerance of nongrowing pneumococci to beta-lactam antibiotics.
    Scand J Infect Dis Suppl. 1990;74:102-12 PMID: 1982975
  24. Killing and regrowth of bacteria in vitro: a review.
    Scand J Infect Dis Suppl. 1990;74:63-70 PMID: 2097720
  25. Adaptive resistance following single doses of gentamicin in a dynamic in vitro model.
    Antimicrob Agents Chemother. 1992 Sep;36(9):1951-7 PMID: 1416886
  26. Mathematical model for comparison of time-killing curves.
    Antimicrob Agents Chemother. 1993 Aug;37(8):1685-9 PMID: 8215284
  27. An unstable small-colony variant of a noninvasive mutant of Salmonella typhimurium is highly invasive for MDCK cells.
    FEMS Microbiol Lett. 1995 Jul 15;130(1):45-9 PMID: 7557295
  28. Relationship between phase variation in colony morphology, intrastrain variation in cell wall physiology, and nasopharyngeal colonization by Streptococcus pneumoniae.
    Infect Immun. 1996 Jun;64(6):2240-5 PMID: 8675333
  29. Pathogenicity island evaluation in Escherichia coli K1 by crossing with laboratory strain K-12.
    Infect Immun. 1996 Aug;64(8):3218-23 PMID: 8757856
  30. In vitro characterization of aminoglycoside adaptive resistance in Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 1996 Jun;40(6):1387-93 PMID: 8726006
  31. A new time-kill method of assessing the relative efficacy of antimicrobial agents alone and in combination developed using a representative beta-lactam, aminoglycoside and fluoroquinolone.
    J Antimicrob Chemother. 1996 Aug;38(2):193-203 PMID: 8877533
  32. The population dynamics of antimicrobial chemotherapy.
    Antimicrob Agents Chemother. 1997 Feb;41(2):363-73 PMID: 9021193
  33. Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model.
    Antimicrob Agents Chemother. 1997 Apr;41(4):823-6 PMID: 9087497
  34. A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly.
    J Bacteriol. 1997 Aug;179(15):4706-12 PMID: 9244256
  35. Postantibiotic effect in Escherichia coli determined with real-time metabolic monitoring.
    Antimicrob Agents Chemother. 1998 Jan;42(1):78-82 PMID: 9449264
  36. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.
    Clin Infect Dis. 1998 Jan;26(1):1-10; quiz 11-2 PMID: 9455502
  37. MIC-based interspecies prediction of the antimicrobial effects of ciprofloxacin on bacteria of different susceptibilities in an in vitro dynamic model.
    Antimicrob Agents Chemother. 1998 Nov;42(11):2848-52 PMID: 9797214
  38. Prediction of the effects of inoculum size on the antimicrobial action of trovafloxacin and ciprofloxacin against Staphylococcus aureus and Escherichia coli in an in vitro dynamic model.
    Antimicrob Agents Chemother. 1999 Mar;43(3):498-502 PMID: 10049257
  39. Bacterial persistence as a phenotypic switch.
    Science. 2004 Sep 10;305(5690):1622-5 PMID: 15308767
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
2005-04-00
Pages
1483-94
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC1068602
Subset
IM
Grants
NIGMS NIH HHS · R01 GM033782 · United States
NIGMS NIH HHS · GM33782 · United States
NIGMS NIH HHS · T32 GM008169 · United States
NIAID NIH HHS · AI40662 · United States
NIAID NIH HHS · R01 AI040662 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com